FDA's Orange Book Doesn't Include Amarin's Vascepa NCE Status in November Report - Bloomberg

Loading...
Loading...
View
Orange Book
.
Posted In: NewsFDA
We simplify the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...